Blunt liver injury in children and adults: is there really a difference?

W Patrick Klapheke1, Glen A Franklin, David S Foley

  • 1Department of Surgery, University of Louisville, Louisville, Kentucky 40292, USA. pklapheke@hotmail.com

The American Surgeon
|September 24, 2008
PubMed

Insights

Outcomes for pediatric liver injuries are similar to adults, with comparable operative rates and overall mortality. However, pediatric patients experienced higher liver-related mortality despite fewer invasive procedures.

Area of Science:

  • Trauma Surgery
  • Pediatric Surgery
  • Hepatobiliary Surgery

Background:

  • Nonoperative management of hepatic injuries is common in adults, utilizing procedures like angiography and ERCP.
  • Limited data exists on pediatric liver injury outcomes and management strategies.

Purpose of the Study:

  • To compare the outcomes, management, and complications of pediatric versus adult blunt liver injuries.
  • To evaluate the necessity of operative intervention and adjunctive therapies in different age groups.

Main Methods:

  • Retrospective review of blunt liver injuries from 2004-2006 in adult and pediatric trauma centers.
  • Comparison of operative intervention rates, use of adjunctive therapies, and patient outcomes (ICU/hospital LOS, mortality).

Main Results:

  • Similar rates of high-grade injuries and primary operative interventions between pediatric (PED) and adult groups.
  • Adults utilized adjunctive therapies (percutaneous drains, angiography, ERCP) more frequently than pediatric patients.
  • Pediatric patients had a higher liver-related mortality rate (50%) compared to adults (0%), despite similar overall mortality and hospital stays.

Conclusions:

  • Pediatric and adult blunt liver injuries share similar injury patterns and operative intervention rates.
  • Adults more frequently require adjunctive procedures for nonoperative management of liver injuries.
  • Pediatric liver injuries are associated with a higher rate of liver-specific mortality, warranting further investigation into management and outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...